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2Abstract
Vertebrate members of the ski/snoN family of proto-oncogenes antagonize TGFβ and
BMP signalling in a variety of experimental situations.  This activity of Ski/SnoN
proteins is related to their ability to interact with Smads, the proteins acting as key
mediators of the transcriptional response to the TGFβ superfamily members.  However,
despite extensive efforts to identify the physiological roles of the Ski/SnoN proteins, it
is not yet clear whether they participate in regulating Activin and/or BMP signalling
during normal development.  It is therefore crucial to examine their roles in vivo, mostly
because of the large number of known Ski/SnoN-interacting proteins and the association
between the up-regulation of these genes and cancer progression.  Here we characterise
the Drosophila homolog to vertebrate ski and snoN genes.  The Drosophila dSki protein
retains the ability of its vertebrate counterparts to antagonize BMP signalling, it is
localized to both the nucleus and the cytoplasm and it does not interfere with Mad
phosphorylation.  The elimination of dski reduces viability and causes female sterility,
but the surviving homozygous flies have wings of normal size and pattern.  We suggest
that the presence of other TGFβ antagonists might make redundant the negative effects
of dSki on signalling mediated by these pathways.  The Ski/SnoN repression of the
pathway might constitute a “security system” for the organism in cases where the TGFβ
signal is unbalanced.
3Introduction
Decapentaplegic (Dpp), a member of the TGFβ/BMP family, plays essential roles
during Drosophila embryonic and imaginal development, influencing cell fate choices,
cell proliferation and differentiation (Gelbart, 1989).  The core elements of the pathway
include the ligand Dpp, the type I and II transmembrane receptors Thick veins (Tkv)
and Punt (Pnt), and the intracellular transducers Mothers against Dpp (Mad, related to
Smad1-5) and Medea (Med, related to Smad4) (for a reviews see (Affolter et al., 2001;
Feng and Derynck, 2005; Massague and Wotton, 2000).  Additional key components of
the pathway are the transcription factors Brinker (Brk) and Schnurri (Shn) and the
antagonist Daughters against Dpp (Dad), related to vertebrate Smad7 (Marty et al.,
2000; Tsuneizumi et al., 1997).  Drosophila also has a TGFβ/Activin pathway, involved
in the control of cell growth during imaginal development, in which the ligand Activin
binds the type I receptor Baboon (Babo) that phosphorylates dSmad2 (Brummel et al.,
1999).  The structure of these pathways is conserved and the mechanism of signal
transduction is similar between vertebrates and invertebrates (Massague and Chen,
2000).  In both pathways, binding of the ligand to receptor complexes triggers receptor
activation, which leads to the phosphorylation of Mad (Tkv/Dpp) or dSmad2
(Babo/Activin).  Once phosphorylated, Mad or dSmad2 interact with Med, forming
complexes that translocate to the nucleus where they can interact with DNA and, in
combination with a number of co-factors, regulate the transcription of their target genes
(Wisotzkey et al., 1998).  Transcriptional regulation mediated by Mad/Med complexes
depends on the cell-type specific cofactors recruited to the DNA.  For instance, in
combination with Shn, Mad/Med negatively regulate the expression of the target gene
brk (Marty et al., 2000; Torres-Vazquez et al., 2000).  Brk, in turn, can recruit several
4co-repressor complexes to the DNA, regulating negatively the transcription of
target genes bearing Brk-binding sequences.  In essence, the response of a target gene to
Dpp signalling is determined both by the combination of Mad/Med and Brk with
specific co-regulators and by the structure of the regulatory DNA regions bound by
them (Barrio and de Celis, 2004; Kirkpatrick et al., 2001; Saller and Bienz, 2001;
Winter and Campbell, 2004).
A variety of mechanisms regulate the activity of the Dpp pathway, including
negative feedbacks that contribute to signal termination mediated by the E3-Ubiquitin
ligase dSmurf and the antagonist effect of Dad.  dSmurf interacts with activated Mad,
triggering its degradation by the proteasome (Liang et al., 2003; Podos et al., 2001).  In
contrast, Dad, itself a Dpp target gene, interferes with the phosphorylation of Mad
through interaction with the Dpp receptor complex (Inoue et al., 1998; Tsuneizumi et
al., 1997).  The TGFβ pathway has been widely studied in vertebrates, where it
regulates a variety of physiological responses including growth inhibition,
differentiation and induction of apoptosis (Massague et al., 2000).  Major negative
regulators of the TGFβ response are the proteins of the Ski/SnoN family, identified by
their ability to induce morphological transformation in chicken and quail embryo
fibroblasts and terminal muscle differentiation in quail embryo cells (Li et al., 1986;
Stavnezer et al., 1986).
The Ski/SnoN proteins appear to antagonize TGFβ signalling using different
cell-type specific mechanisms.  First, Ski/SnoN, acting in the nucleus, displace the
Smad co-activators p300/CBP and recruit the co-repressors N-CoR/SMRT and mSin3A,
forming macromolecular complexes with the histone deacetylase complex (HDAC)
5(Nomura et al., 1999).  In this manner, in the presence of high levels of Ski/SnoN,
gene expression is not activated in response to TGFβ signalling.  Second, and to account
for Ski/SnoN augmented DNA binding of Smad complexes in the absence of receptor
activation, it was proposed that Ski/SnoN stabilize inactive Smad complexes bound to
the DNA, explaining the ability of these proteins to antagonize TGFβ signalling by
promoting gene expression, as it happens with some promoters (Luo et al., 1999; Sun et
al., 1999).  Finally, Ski/SnoN, acting in the cytoplasm, can interfere and reduce the
ligand-dependent phosphorylation of Smad2/3, preventing their translocation to the
nucleus (Prunier et al., 2003).  The relationships between Ski/SnoN and TGFβ
signalling has been primarily studied in experimental conditions of increased expression
of these proteins, a situation that relates mainly to the progression of a large number of
human tumours, where high levels of Ski/SnoN proteins are usually associated with
poor clinical prognosis (Buess et al., 2004).
In addition to the Smads, several other Ski-interacting proteins have being
identified in biochemical assays.  Thus, Ski interacts with GATA1 and blocks the
binding of GATA1 to DNA in a TGFβ signalling-independent manner (Ueki et al.,
2004).  Ski also interacts with c-Myb to negatively regulate its activity by recruiting
HDAC complexes to the DNA (Nomura et al., 2004).  In a similar manner, c-Ski is
required for the transcriptional repression mediated by Retinoblastoma (Rb), which
binds directly to c-Ski and HDAC (Prathapam et al., 2002; Tokitou et al., 1999).  Ski
also associates with the Retinoic Acid Receptor complex, and can repress transcription
from a Retinoic Acid Response Element (Ritter et al., 2006).  Finally, Ski has also been
found in association with other cellular proteins not related to transcriptional control,
such as α -tubulin in the mitotic spindle and centrosomal proteins (Marcelain and
6Hayman, 2005).
The physiological roles of Ski/SnoN have also been analysed in vivo, by
studying knockout mice deficient for the ski or snoN genes and analysing the daf-5
mutant in C. elegans (da Graca et al., 2004; Tewari et al., 2004).  DAF-5 is an
orthologue of SnoN and Ski, being the first example of a Ski/SnoN protein with a
genetically defined function in a TGFβ pathway, where in combination with Daf-3, it
acts in a neurosecretory process to control C. elegans dauer developmental arrest.  In the
case of vertebrate SnoN, contradictory results have been reported because one snoN-null
line shows embryonic lethality before E3.5 (Shinagawa et al., 2000) and two other snoN
deletions are viable and only show defects in T cell activation (Pearson-White and
McDuffie, 2003).  In any case, it is not clear whether the observed phenotypes are
related to a lack of repression of TGFβ signalling.  Similarly, it is also not clear whether
the typical abnormalities of ski-deficient mice, such as neural tube defects, postaxial
polydactyly and eye defects, are related to TGFβ activity (Berk et al., 1997; Colmenares
et al., 2002).  Finally, HKC cells after transfection with snoN specific siRNA displayed
a greater responsiveness to TGFβ-1 stimulation, suggesting that down-regulation of
snoN lowers the threshold of TGFβ-1 responsiveness by amplifying TGFβ-1 signalling
(Yang et al., 2003).
In this work, we describe the genetic and functional characterisation of the
Drosophila gene dski, an orthologue of both vertebrate ski and snoN.  To thoroughly
analyse the relation between dSki and the TGFβ pathway, we have chosen the wing
imaginal disc as experimental system.  The wing disc is the epithelium that gives raise
to the thorax and wing of the fly, and the role of both Dpp and Activin signalling in the
control of growth and patterning of the disc have been carefully studied (Brummel et al.,
71999; Zecca et al., 1995).  We identified dski in an over-expression screen aimed
to identify genes affecting the differentiation of the veins, and found that increased
expression of dski causes phenotypes reminiscent of loss of Dpp activity in the adult
wing, legs and thorax.  These phenotypes are associated to the failure of Dpp to regulate
the expression of its target genes in the presence of high levels of dSki, a situation that
mirrors the relations between vertebrate Ski/SnoN and the TGFβ signalling pathway.
The augmented expression of dSki does not interfere with Mad phosphorylation, and its
effect is completely abolished by mutations in the putative Smad 2/3 or Smad4-binding
regions of dSki.  Surprisingly, we did not find a significant phenotype in the wing upon
removal of dski, and therefore we suggest that during normal wing development the
contribution of several overlapping mechanisms makes redundant a role for dski to
regulate Dpp signalling.  In dSki over-expression conditions, the interaction between
dSki and Mad/Med cannot be relieved by pathway activation, and the transcriptional
regulation of Dpp-target genes is compromised.
Results
Ectopic expression of dSki causes loss of Dpp signalling
Genetic combinations between the P-UAS insertion EP-M67 and a variety of
Gal4 lines expressed in the imaginal discs result in striking adult phenotypes (Fig. 1).
The modifications observed in the wing vary, depending on the particular Gal4 line,
from moderate wing size reduction and vein loss (Gal4-sal/EP-M67; Fig. 1B) to strong
wing size decrease accompanied by the absence of all veins (Fig. 1C-D; nub-Gal4/EP-
8M67 and 638-Gal4/+; EP-M67/+).  In the thorax, the combinations ptc-Gal4/EP-
M67 and pnr-Gal4/EP-M67 display a complete failure in the closure between the two
heminota (Fig. 1I and data not shown), whereas in the legs the combination dll-
Gal4/EP-M67 shows failures in anterior-posterior leg patterning and the absence of
distal segments (Fig. 1K).  Interestingly, all these phenotypes are similar to those caused
by the reduction in dpp expression or signalling (Fig. 1E and see Campbell et al., 1993;
de Celis, 1997).  These facts suggest that the gene/s targeted by the EP-M67 insertion
interfere negatively with some aspect of the Dpp signalling pathway.
The EP-M67 insertion is localised between the 5’ regions of two annotated
genes, CG7233 and CG7231 (Fig. 2).  Because the P-GS element carries UAS
sequences at both ends, both genes can be simultaneously expressed in EP-M67/Gal4
combinations (Molnar et al., 2006; Toba et al., 1999), and this is indeed what we
observed (Fig. 2D and data not shown for CG7231).  To identify unambiguously the
gene responsible for the ectopic expression phenotypes, we generated UAS and UAS-
RNAi transgenic lines for the coding regions of CG7233 and CG7231.  We found that
only the over-expression of CG7233 reproduces the phenotype of the EP-M67 insertion
(Fig. 1G).  Likewise, only the UAS-CG7233i line is able to suppress the phenotype of
EP-M67/Gal4 combinations (Fig. 1F).  These data indicate that the miss-expression of
CG7233 accounts for all the phenotypes observed in combinations involving EP-M67.
Furthermore, some suppressors of the EP-M67 phenotype are characterized by amino
acid changes in the CG7233 coding region (see below), further confirming its
association with the EP-M67 miss-expression phenotypes.
9Genomic structure and RNA expression of dski
The gene CG7233, as annotated in Flybase, is formed by a unique exon with an
open reading frame of 1017 bp with no EST clone associated (Fig. 2A).  Therefore, we
searched for cDNA clones containing the CG7233 sequence by PCR in cDNA libraries
constructed from embryonic and imaginal polyA+ RNA (Brown and Kafatos, 1988).
We identified two polyA+ cDNAs expressed throughout development, named cDNA3.2
and cDNA7.1.  cDNA7.1 includes CG7233, whereas cDNA3.2 includes in addition part
of CG7093, a gene annotated proximal to CG7233 (Fig. 2A).  These data indicate that
dski generate two alternative transcripts, which we named dski-Short (CG7233; dskiS)
and dski-Long (CG7233 plus CG7093; dskiL).  Thus, the intergenic region between
CG7233 and CG7093 corresponds to a long intron of 80Kb.  To verify the existence of
this intron, we performed RT-PCR reactions using mRNA from embryos, larvae and
wing imaginal discs and sets of primers specific for CG7233 (a), CG7093 (c) and the
joint between the two of them (b).  The results corroborated the existence of alternative
splicing (Fig. 2B).  Interestingly, the same genomic organization was found in D.
pseudoobscura (not shown) and A .  gambiae (Fig. 2C).  However, sequences
homologous to CG7093 were not found in other species.
By means of in situ hybridization using probes for the common region of dskiS
and dskiL and for the unique exon of dskiL, we found that both transcripts are expressed
under UAS control in combinations between EP-M67 and Gal4 lines (Fig. 2D).
However, the phenotype of EP-M67  appears to be causally related only to the
misexpression of dskiS, because the UAS-dskiL in combination with several Gal4 lines
did not affect adult patterning or growth (data not shown).  In wild type imaginal discs
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the expression of both dskiS and dskiL is generalised (Fig. 2D for the wing disc
and data not shown).
dskiS contains a Ski domain, present in the ski/snoN family of proto-oncogenes,
and it has been identified as the Drosophila SnoN orthologue (Flybase).  However, our
phylogenetic analysis suggests that dSki is equidistant from the Ski and SnoN vertebrate
paralogues (called previously Snowski (da Graca et al., 2004), indicating that the
duplication ski/sno occurred after the separation of the arthropods (Fig. 3A).  The fact
that T. castaneum presents a unique ski/sno homologue equally distant from ski and
snoN reinforces this idea (not shown).  Other proteins containing Ski domains are
grouped in two distinct families (Fig. 3A).  Dachshund (Dac) proteins are negative
regulators of the TGFβ signally through their interaction with Smad4, as reported in
vertebrates (Wu et al., 2003).  In Drosophila, Dac does not seem to have a function in
the wing blade but is able to produce ectopic eyes when co-expressed with eyes absent
(Chen et al., 1997; Hammond et al., 1998).  The CG11093 family (previously called
Iceskate (da Graca et al., 2004), which is poorly characterised, represents the third
branch.  Two subfamilies can be differentiated in vertebrates.  In humans, the closer
homologue to CG11093 is Fussel-18, which is expressed exclusively in the nervous
system and interacts with Smad2 and 3 (Arndt et al., 2005).  Closely related is the
Ladybird homeobox corepressor 1 (LBXCO1) sub-family, which homologue in mice,
Corl1, is expressed exclusively in brain and testis and interacts with the Ladybird
homeobox protein (Arndt et al., 2005; Mizuhara et al., 2005).  These data indicate that
Drosophila has representative orthologues for the three branches of the Ski superfamily,
but a unique member belonging to the Ski/SnoN family (Fig. 3A).
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Interactions between dSki and the Dpp pathway
Vertebrate Ski/SnoN proteins have been extensively characterised by
biochemical and cell culture approaches, behaving as strong antagonists of the Activin
and BMP signalling pathways (see Introduction).  The phenotype caused by increased
expression of dskiS suggests that such antagonism is conserved in Drosophila.  To
understand the molecular bases of this interaction, we monitored the effects of dski
over-expression on the expression of several Dpp targets in the wing imaginal disc.  We
used target genes that are activated by Dpp signalling such as dad, spalt (sal),
optomotor blind (omb) and blistered (bs) as well as brk, which expression is repressed
by Dpp activity (Fig. 4).  We compared the effects of dSki with those of the Dpp
antagonist Dad and of the Brk repressor.  We found that increased expression of dski
reduces the expression of Sal and dad with high efficiency and interferes weakly with
the expression of omb and Bs (Fig. 4G-J).  In addition, the expression of brk, normally
restricted to the most anterior and posterior part of the wing blade by Dpp repression, is
now observed throughout the wing blade (Fig. 4K).  These effects are very similar to
those of ectopic Dad or Brk, the main differences being the degree with which each Dpp
target gene is affected (Fig. 4M-Q,S-W).  Thus, Brk is more efficient than Dad or dSki
in repressing omb and bs, and dSki is more efficient that Dad or Brk in repressing dad
(Fig. 4).  Ectopic expression of dSki, Dad or Brk interfered the repression of brk in the
centre of the wing blade with similar efficiency (Fig. 4K,Q,W).  These data indicate that
dSki antagonises Dpp targets gene expression, acting both on genes that are normally
activated (sal, dad) or repressed (brk) by Dpp signalling.  Because Mad/Med contribute
to both activation and repression of Dpp targets (Muller et al., 2003), it is likely that the
effect of dSki is exerted on the formation or activity of Mad/Med complexes.
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dSkiS does not modify Mad phosphorylation, but interferes with Mad/Med complexes
To further characterise the relationship between dSki and the Dpp pathway, we
analysed genetic combinations between dSki and several members of the pathway in
misexpression experiments.  Ectopic expression of activated-Tkv (Tkv*) or activated-
Babo (Babo*) in the centre of the wing, the domain where the Dpp pathway is normally
active, modifies wing size, the pattern of veins and the integrity of the wing (Fig. 5AI,II).
In contrast, ectopic expression of Mad, Med or dSmad2 in the same central domain does
not modify wing growth or patterning (Fig. 5AIII-V).  The co-expression of dSki rescues
the phenotypes caused by ectopic Tkv* or Babo* (Fig. 5BI,II) resulting in wings very
similar to those over-expressing only dSki (see Fig. 1).  These results indicate that dSki
functions downstream of the activated receptors.  In contrast, the expression of Mad and
Med suppresses the phenotype of dSki, giving rise to wings of normal size and pattern
(Fig. 5BIII,IV), suggesting that dSki interferes with the formation or activity of Mad/Med
complexes.  Similar results were obtained when the ectopic expression was driven in the
entire wing, including the territories where the Dpp pathway is not normally active.  In
these cases, the over-expression of Mad, Med or dSmad2 caused a mutant phenotype
consisting of alterations in the vein pattern and wing size (Fig. 5CIII-V).  The phenotypes
of these combinations with over-expressed dSki confirms that only Mad or Med are able
to suppress dSki, whereas dSki efficiently suppresses the phenotype of ectopic Tkv* or
Babo*  (Fig. 5DI-IV).  Interestingly, we found a strong synergistic interaction between
dSki and dSmad2, consisting in the generation of very small wings without veins,
similar to those of strong dpp-disc alleles (Fig. 5DV).  Possibly, the formation of
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Med/dSmad2 dimmers could reduce the formation of Mad/Med functional
dimmers, already severely compromised by the presence of dSkiS (see Discussion).
The genetic interactions between dSkiS and the elements of the Dpp and Activin
pathways can be interpreted as a consequence of sequestering Mad or Med by dSkiS or,
alternatively, by the failure to phosphorylate Mad in the presence of dSkiS.  We studied
in vivo the distribution of phosphorylated-Mad (PMad) in the presence of dSkiS or Dad,
which is known to interfere with Mad phosphorylation (Fig. 5E-J).  When dSkiS
expression is increased, the phosphorylation of PMad is not modified (Fig. 5F), even in
the presence of Tkv* (Fig. 5I).  These data indicate that, at least in the wing disc, dSkiS
does not interfere with Mad phosphorylation, suggesting that interactions between
dSkiS and Mad or Med underlies the negative effects of dSkiS on Dpp signalling.
Generation and analysis of dski loss of function alleles
We have shown that over-expression of dSki interferes with Dpp signalling
probably through interactions with Mad and/or Med.  In order to analyse the
requirement of the gene during normal development, we generated a deficiency that
removes all dSkiS coding sequences, as well as several point mutations that prevent the
negative regulation of Dpp signalling.  The dski deficiency is a 65Kb deletion induced
by FRT-based recombination between the insertions f00844 and d02797, and includes
the genes dskiS, most of dskiL, CG7231 and most of CG7228.  Homozygous flies
Df(2L)ski are homozygous viable, albeit the viability is only of 30%.  The surviving
flies have wings of normal size and pattern, and the females are sterile.  Furthermore,
the expression of Sal and P-Mad is not affected in Df(2L)ski wing imaginal discs (data
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not shown).  Point mutation alleles in the dski coding region were induced by
chemical mutagenesis as revertants of the EP-M67 insertion, taking advantage of the
strong dpp-like phenotype of the combination Gal4-638/EP-M67 (Fig. 6B).  Out of the
eight mutants isolated and mapped to the coding region of dSki, three, M672C3, M673K1
and M673W1 behave as complete revertants (Fig. 6).  M672C3 is caused by an F234I
substitution in the dSkiS region corresponding to the Smad4 binding domain of
vertebrate Ski (Fig. 6A).  Interestingly, this phenylalanine is important to establish
hydrogen bounds with several amino acids in Smad4 (Wu et al., 2002), suggesting that
the 2C3 mutant protein has reduced ability to interact with Med/Smad4.  The dSki2C3
protein is still able to cancel some of the effects of ectopic Mad expression (Fig. 6J-M).
M673W1 also maps in the Smad4 binding domain, and M673K1 is a P71S substitution in a
Smad2/3 interacting domain identified by (Ueki and Hayman, 2003).  We also identify
several partial revertants, three of them causing amino acid substitutions in the
Med/Smad4 binding domain (R102: S247F; S2: V269M and V2: F285L; Fig. 6A), in
the Ski domain (F3: I182T; Fig. 6A) and in the C-terminal region of dSkiS (K2: E329L;
Fig. 6A), suggesting that these regions are also critical for dSki activity.  The C-terminal
sequence of dSki (ELEHKKRKVRWV) includes a putative consensus nuclear
localization signal (Fig. 7).  However, no major differences were found between the
sub-cellular localization of dSkiS-GFP or dSkiSΔC-GFP, a construction that lacks the
C-terminal part of the protein (see below).  We did not find any revertant in the non-
conserved amino terminal part of dSkiS or in the dSkiL unique C-terminal region, even
through these regions account for most of the dSki protein sequences.  These data
suggest that the effect of dSkiS on Dpp signalling requires an intact Smad4 and
Smad2/3 interacting domain, as well as the Ski and the C-terminal domains.
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All EP-M67 revertant chromosomes were lethal in homozygosis, although
the lethality is not related to mutations in dski but to second site mutations.  Thus, (1) all
pair-wise combinations between EP-M67 revertants are viable and lack a visible
phenotype, (2) heterozygous between these revertants and the Df(2L)dski are fully
viable.  Trans-heterozygous females between any dski revertant and Df(2L)dski are
fertile and complete oogenesis normally, indicating that the defects observed in
Df(2L)dski homozygous can not be directly attributed to dSki interacting with Mad/Med
complexes.
Subcellular localisation of dSki in imaginal discs
We generated dSki-GFP fusion proteins and studied their subcellular
localizations in the wing imaginal disc (Fig. 7).  The level of GFP expression in the
combination Gal4-nub/UAS-GFP was very similar in all wing cells during the third
larval instar (data not shown).  In contrast, we found that the levels and subcellular
localisation of the GPF signal was extremely heterogeneous within each wing disc in
Gal4-nub/UAS-dSkiS-GFP (Fig. 7E, G).  In general, the protein is localised in both the
nucleus and the cytoplasm, but the levels of GFP in these cellular compartments vary in
different cells.  In addition, GFP cannot be detected in cells distributed homogeneously
in clusters throughout the wing blade.  We did not find any correlation between the
pattern of dSkiS-GFP expression and the domain of Dpp activity.  Furthermore, the
distribution of dSkiS-GFP is not modified when the activity of the pathway is altered,
either by expressing Tkv* or Med (Fig. 7 F,H).  All together, these data indicate that, in
our experimental settings, Dpp signalling does not interfere with the stability and
subcellular localization of dSkiS.
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Subcellular localization and activity of dSki in cultured cells
To better understand the regulation of dSki subcellular localization, we
introduced the Ski-GFP fusion proteins into mammalian cells with or without other
components of the Dpp pathway (Fig. 8).  When dSkiS-GFP is introduced alone, the
protein appears both in the nucleus and the cytoplasm and this distribution does not
change in the presence of Mad (Fig. 8A,E).  However, when transfected together with
Med, dSkiS-GFP is retained in the cytoplasm, as it has been reported for Med alone
(Wisotzkey et al., 1998 and Fig.8C).  The normal localization of dSkiS-GFP is
recovered only when the Dpp pathway is active in the presence of Mad (Fig. 8H,
compare to 8D and 8G).  These results suggest that dSkiS interacts with Med in the
cytoplasm and translocates to the nucleus, together with Med and Mad, when the
pathway is active.  Our results do not show any interaction between dSkiS and Mad.
Whether this interaction exists or not, its nature seems to be weaker than the interaction
of dSkiS with Med, as in the presence of Mad and Med, dSkiS is still retained in the
cytoplasm (Fig. 8G).  Interestingly, no major differences were seen in the localization of
dSkiSΔC-GFP (data not shown), confirming that the C-terminal region is not necessary
for the nuclear localization of the protein, neither for its interaction with Med. dSkiL-
GFP behaves differently than dSkiS-GFP and is always retained in the nucleus despite
the presence of Med or the activation of the Dpp pathway (Fig. 8I-J).
In order to understand the functionality of the dSki isoforms, we performed
transcriptional assays using the mammalian TLX2 responsive element next to the
luciferase reporter gene. This construction has been shown to respond to the Drosophila
homologues of the TGFβ pathway (Brummel et al., 1999; Tang et al., 1998).  The
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reporter is moderately activated in presence of Tkv*, Mad and Med, but this
activation diminishes significantly when either dSki isoform is introduced in the culture
(Fig. 8K). These results indicate that the dSki proteins are able to inhibit the activation
of a TGFβ responsive element in cell culture.  The TGFβ pathway inhibits the cellular
growth, probably through the inhibition of cell proliferation (Huang and Huang, 2005).
When added to P19 cells, Tkv*, Mad and Med decrease cell viability by more than a
40% (Fig. 8L).  However, this inhibition is counteracted significantly by the addition of
either the dSki isoforms.  Interestingly, the presence together of dSkiS and dSkiL
reduces viability, suggesting that the two isoforms can counteract each other when
expressed at high levels in cultured cells.
Discussion
We report here the characterization of the Drosophila homologue to vertebrates
Ski and SnoN, and its relationships to Dpp signalling.  dski is transcribed into two
isoforms, dskiS and dskiL, with dSkiS being able to interfere with Dpp signalling when
expressed at levels higher than normal.  These effects of dSkiS are suppressed by
increasing the expression of either Mad or Med, suggesting that, when over-expressed,
dSkiS titrates out Mad/Med complexes, and renders them non-functional.  In this
manner, the antagonism of dSki on Dpp signalling affects indistinctively the Dpp-
targets that are activated (dad, sal and omb) or repressed  (brk) by the pathway.  The
elimination of dSkiS and dSkiL by a genetic deficiency did not affect Dpp signalling in
the imaginal discs.  This result is surprising because Ski/SnoN are among the best-
known negative regulators of BMP and TGFβ signalling in vertebrate cells and several
molecular mechanisms linking Ski/SnoN and the Smad proteins have been identified
18
(see introduction).  Interestingly, the overwhelming majority of studies relating
Ski/SnoN to BMP and TGFβ signalling pathways are based in experiments where Ski
and/or SnoN are over-expressed (Luo, 2004). Our work shows that the ability of
Ski/Sno to antagonise BMP signalling is conserved in Drosophila and vertebrate cell
lines, but brings the physiological significance of these effects during normal
development into question.
dSkiS effects on Dpp signalling depends on its Mad and Med binding domains
All the defects we observed in imaginal discs and adult patterns after increased
expression of dSkiS can be constructed as the result of reduced Dpp signalling.  Thus,
the phenotypes of dskiS over-expression are extremely similar to those characteristics of
dpp loss-of-function mutations, and the expression of Dpp target genes is severely
impaired upon dskiS ectopic-expression.  Finally, the interference with Dpp-target
expression and the mutant phenotypes characteristic of increased dSki depend on the
integrity of its Mad- and Med-binding domains.  We could not observe effects of dSkiS
over-expression on Mad phosphorylation, indicating that the pathway is activated in its
normal spatial domain.  Furthermore, ectopic expression of dSki cancels the effects of
activated Tkv, while it is cancelled by augmented levels of either Mad or Med.  These
results indicate that the effect of dSki is related to its binding to the P-Mad and Med
proteins, preventing them to form functional complexes.  The subcellular location of
dSkiS-GFP in cultured cells is compatible with direct interaction of dSkiS with Med,
because these proteins are retained together in the cytoplasm when P-Mad is not
present.  In the wing disc, however, other mechanisms must contribute to dSkiS
subcellular localization, because the protein is detected in both the nucleus and
cytoplasm in cells where P-Mad is not present and Med is preferentially located at the
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cytoplasm.  In addition, other Dpp-independent mechanisms contribute to the
stability of the fusion protein, because cells grouped in clusters in the wing disc fail to
accumulate dSkiS-GFP.  The importance of dSkiS interactions with Med is highlighted
by the genetic interactions we observed between dSkiS and the Activin pathway
members Babo* and dSmad2.  Therefore, we suggest that dSkiS interferes with both the
Dpp and Activin pathways, which share Med as a partner for Mad and dSmad2,
respectively (Brummel et al., 1999).
In vertebrates, it appears that Ski/SnoN binds R-Smads (dSmad2/Smad2-3 and
Mad/Smad1-5) and Smad4 independently, using different domains in the Ski protein
(He et al., 2003; Ueki and Hayman, 2003; Wang et al., 2000; Wu et al., 2002).  It is not
clear, however, whether mutations in both the R-Smad and Smad4 ski-interacting
domains are needed to suppress Ski/SnoN activities.  Thus, in some assays, removing
Smad4-Ski interactions is enough to cancel the effects of Ski on TGFβ (Suzuki et al.,
2004) or BMP signalling (Takeda et al., 2004), whereas other reports suggests that Ski
proteins defective in binding to only Smad2/3 or Smad4 retain their activity (He et al.,
2003; Ueki and Hayman, 2003; Wu et al., 2002).  We observed that single dski mutants
in the dSmad2/Smad2-3 binding domain recently identified by (Ueki and Hayman,
2003) or in the Med/Smad4 binding domain severely compromise the ability of the dSki
to interfere with Dpp signalling.  In other words, dski mutants reducing or abolishing
the phenotype of dSki ectopic expression map in either its Smad4 binding region (2C3,
R102, S2, 2W1 and V2 see Fig. 6) or in its Smad2/3 binding domain (3K2).  In this
manner, although our in vivo data support the importance of both the R-Smad and
Smad4 binding sites on dSkiS, they also indicate that the antagonism of dSki on Dpp
signalling requires its interaction simultaneous with both P-Mad and Med.
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dSki subcellular location
The subcellular localization of Ski proteins varies in different cell types and
physiological situations.  In most cases, Ski has been reported as a nuclear protein,
although it can be kept in the cytoplasm, restricting TGFβ signalling by Smad2
sequestration (Kokura et al., 2003).  In mouse liver hepatocytes, C184M, a small
leucine-rich protein that represses growth cell inhibition by TGFβ, could retain Ski in
the cytoplasm (Kokura et al., 2003).  In pre-invasive melanomas Ski is located only in
the nucleus while it appears in the cytoplasm in primary invasive and metastatic
melanomas (Reed et al., 2001).  SnoN is predominantly cytoplasmic in normal tissues
and in non-tumorogenic or primary epithelial cells.  After cell-cycle arrest, SnoN
translocates into the nucleus (Krakowski et al., 2005).  In the Drosophila wing disc the
localization of the protein when over-expressed occurs in both the nucleus and the
cytoplasm, and this pattern appears independent of Dpp signalling, because it does not
correlate with the spatial domain of Dpp activation (P-Mad expression) and it is not
modify upon manipulation of pathway activity.  In mammalian cells, however, the
location of dSkiS can be modulated by the activation of the Dpp pathway, mainly
through the interaction of dSkiS with Med.  Thus, the phosphorylation of Mad by Tkv*
promotes its translocation to the nucleus accompanied by Med, which in turn can
transport dSkiS.  Taking dSkiS to the nucleus along with the activated Smads could
ensure the down-regulation of the pathway to avoid an excess of signal.
Developmental role of dSki in Drosophila
Despite the fact that the wing is an excellent system to demonstrate the capacity
of dSkiS to antagonize the Dpp pathway, our genetic analysis does not reveal a role of
this protein during normal wing patterning.  To explain the lack of a prominent function
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for dSkiS in the wing, we could argue that dSkiS function is carried out by another
homologue of the Ski super-family in Drosophila (see Fig. 3).  However, we think this
is unlikely.  Dac is not expressed in the wing blade, except in some cells at the wing
margin, and it does not seem to have a requirement there (Mardon et al., 1994).
However, similarly to dSkiS, Dac is also able to interfere with wing development in
over-expression experiments (Chen et al., 1997).  Also, CG11093 is not a likely
candidate; it is not expressed in the wing imaginal disc and, as it happens for its
mammalian counterparts, its expression seems to be restricted to the nervous system (F.
Casares, personal communication).  Alternatively, a requirement for dSki during normal
wing development might be hidden due to the existence of complementary mechanisms
that contribute to Dpp signal down-regulation.  For example, the lack of dSkiS could
augment Dpp signalling and, consequently, the amount of negative regulators of the
pathway, such as Dad, whose expression is regulated by the pathway (Briones-Orta et
al., 2006; Tsuneizumi et al., 1997).  Increased expression of Dad might counteract the
effect of reduced dSki.  Interestingly, dad homozygous flies only have minor
phenotypes in the wing, which is compatible with a cooperative effect between different
repressors (J. F. de C., unpublished).  In this context, it is remarkable the paucity of data
that relate Ski/Sno activity to BMP/TGFβ signalling in loss-of-function experiments.
The analysis of ski or sno mutant mice show a variety of developmental defects
consistent with their role in various signalling pathways but it does not immediately
relate them to BMP/TGFβ signalling (Berk et al., 1997; Colmenares et al., 2002).  Only
in C. elegans mutants for the ski/snoN homologue daf-5 suggests its involvement in one
aspect of TGFβ signalling (da Graca et al., 2004; Tewari et al., 2004).
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Although the capacity of Ski proteins to interact directly with a wide
variety of factors (see introduction) makes feasible a involvement for these proteins in
multiple developmental pathways, the promotion of oncogenic transformation by Ski or
SnoN proteins is related to their capacity to inhibit the TGFβ pathway (Buess et al.,
2004; Poser et al., 2005; Reed et al., 2001; Zhang et al., 2003; Zhu et al., 2005).  Thus,
the function of dSkiS, which is not apparent during normal wing development, might be
manifested when Dpp/TGFβ signalling is des-regulated.  For example, mice deficient
for ski are more susceptible to generate tumours when exposed to a chemical carcinogen
(Shinagawa et al., 2001).  In the same way, dSkiS could be important for cell behaviour
when challenged with factors or mutations that alters the levels of Dpp signalling.  In
this manner, dSki repression of the pathway might constitute a “security system” for the
organism in cases where the TGFβ signal is unbalanced.  Interestingly, interfering with
the ability of dSki to interact with Smad proteins does not seem to compromise any
critical physiological function of these proteins, making Ski/Sno a suitable target for
cancer therapies.
Materials and Methods
Drosophila melanogaster strains and phenotypic análisis
We isolated one P-GS insertion in the 5’ UTR of CG7233 (EP-M67) in a
mutagenesis screen designed to identify genes affecting vein differentiation (Molnar et
al., 2006). We also used the following Drosophila UAS lines: UAS-tkvQD (Nellen et al.,
1996), UAS-dpp (Staehling-Hampton and Hoffmann, 1994), UAS-brk, UAS-Mad, UAS-
Med, UAS-baboact, UAS-dSmad2 and UAS-GFP (Ito et al., 1997). We also used the Gal4
lines Gal4-shv3kpn (Sotillos and de Celis, 2006), Gal4-dll, Gal4-nub and Gal4-salEPv
(Barrio and de Celis, 2004), Gal4-638 and Gal4-253 (de Celis et al., 1999) and the P-
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lacZ reporter lines dad-lacZ, brk-lacZ, tkv-lacZ and omb-lacZ.  All stocks not
described in the text can be found in Flybase (http://www.flybase.net/).  All phenotypes
were analysed at 25ºC and flies were mounted for microscopic examination in lactic
acid-ethanol (1:1). Pictures were taken in an Axiophot microscope with a Spot digital
camera and processed using Adobe Photoshop.
Generation of dski alleles by chemical mutagenesis
Loss-of-function alleles were induced by chemical mutagenesis, treating
isogenic males of w; EP-M67/EP-M67 genotype with 20mM EMS or ENU, according
to (Lewis and Bacher, 1968).  Treated males were mass-crossed with Gal4-638 females
and viable progeny of genotype Gal4-638;EP-M67/+ were isolated to make the stocks
w; EP-M67-rev/CyO.  The Gal4-638; EP-M67/+ males do not hatch from the pupal case,
and the sibling females (Gal4-638/+; EP-M67/+) display a strong reduction in wing
size and elimination of wing pattern elements.  Among 15000 progeny (viable females
with wing size reduction phenotype) we isolated three complete revertant, named EP-
M672c3, EP-M673K1 and EP-M673W1and six partial revertants: EP-M671D1, EP-M67F3, EP-
M67S2, EP-M67V2 EP-M67K2 and EP-M67R102.  The presence of mutations in all
revertants was confirmed by sequencing the coding region of dskiS (Supplementary
Materials and Methods).
Generation of dski deficiencies by FRT-mediated recombination
We used the Exelixis flanking insertions f00844 and d02797 (Parks and al., 2004)
separated by 65 Kb including dskiS, CG7231 and most of dskiL and CG7228 coding
regions.  FRT recombination was induced by a daily one hour heat shock at 37ºC to the
progeny of hsFLP1.22/+; f00844 / d02797 females and w;CyO/If males.  40 putative
24
f00844-d02797/CyO offspring males were individually crossed to w,CyO/If
females, and after three days were used to extract genomic DNA to confirm by PCR the
existence of FRT recombination.
cDNA isolation and expression analysis
cDNAs 3.2 and 202 were isolated from a 12-24 hr embryonic library and cDNA
7.1 from an imaginal disc library by PCR (Brown and Kafatos, 1988).  Accession
numbers are: cDNA7.1, AM282580; cDNA3.2, AM282581; cDNA202, AM282582. For
RT-PCR experiments mRNA was prepared from D. melanogaster embryos 12h to 24h
old, larva 3 L3, and wing imaginal discs.  The mosquito amplifications were obtained
from an adult abdomen cDNA library.  Detailed protocols and sequences for all the
primers will be provided upon request.
DNA constructions, sequence analysis and generation of transgenic flies
dskiS was generated by a combination of cDNA202 with cDNA7.1. dskiL is a
combination of cDNA202 with cDNA3.2 and EST GH28569 (Flybase).  Accession
numbers are: dskiS, AM282583; dskiL, AM282584. Cloning of dskiS and dskiL GFP-
fusion proteins and UAS constructs, as well as generation of UAS-CG7231, of templates
for in situ probes, of CG7233 RNAi construct and of CG7093 RNAi construct, together
with the sequences of all the primers used and the accession numbers of the sequences
included in the analysis will be provided upon request.  All the clones were verified by
sequencing and all the UAS constructs were introduced in the germ line by P-element
transformation as described (Spradling and Rubin, 1982).  For sequence comparison and
analysis we used ClustalW package.
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Tissue culture, transfection, immunocytochemistry and reporter assays
Mouse embryonic carcinoma P19 cells (ATCC) and Cos1 cells were
transformed in 24 well plates with the appropriated plasmids. For
immunohistochemistry, Cos1 cells were grown on coverslips and stained with mouse
monoclonal anti-Ha 12CA5 (dilution 1:200; Sigma) and rabbit anti-Flag antibodies
(dilution 1:2000; Sigma) using standard procedures. Samples were analyzed in a Leica
confocal microscope. Luciferase assays and viability assays were done in P19 cells
using the Dual-Luciferase Reporter Assay System and CellTiter-Glo, respectively
(Promega). Average, standard deviation and P-test values for each condition originate
from at least 20 independent experiments and were calculated using Microsoft Excel.
Drosophila inmunocitochemistry and in situ hybridization
We used mouse monoclonal anti-DSRF (Hybridoma bank) and rabbit anti-Sal
(dilution 1:200; Barrio et al., 1999) and anti-βGal (dilution 1:200; Cappel). Secondary
antibodies were from Jackson Immunological Laboratories (used at 1/200 dilution).
Third instar imaginal discs were dissected, fixed and stained as described in (de Celis,
1997).  Confocal images were captured using a BioRad confocal microscope.  In situ
hybridization in imaginal discs was carried out as described in (de Celis, 1997). Sense
and anti-sense digoxigenin-labeled RNA probes were prepared with T7, T3 or SP6
RNApolymerases using the appropriated plasmid clones as templates.
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Figure legends
Figure 1
Wing phenotypes caused by increased expression of dSki
(A) Wild-type wing showing the longitudinal veins (L2-L5).  (B-D) Adult wings of
genetic combinations between the P-UAS insertion EP-M67 and the Gal4 lines Gal4-sal
(B), Gal4-nub (C) and Gal4-638 (D).  (E) Homozygous dppd5 wings.  (F) Adult wing of
Gal4-sal/UAS-idSkiS; EP-M67/+ genotype, showing a complete suppression of the EP-
M67  phenotype shown in B.  (G) Adult wing of Gal4-nub/UAS-dskiS genotype,
compare with C.  (H) Wild-type notum.  (I) Gal4-ptc/EP-M67 notum, showing a failure
to close the two heminota (arrow). (J) Wild-type legs.  (K) Gal4-dll/EP-M67 legs,
showing distal truncations characteristic of dppdisc alleles.  All wings, nota and legs
correspond to female flies, and pictures were taken at the same magnification.
Figure 2
Molecular analysis and expression of dski
(A) Schematic representation of the genomic region 28D2-D3 according to Flybase.
Blue boxes represent predicted ORFs and green boxes represent ESTs.  The red triangle
indicates the insertion site of EP-M67.  The location of the two dski isoforms, dSkiS and
dSkiL, is indicated.  The dskiS and dSkiL cDNAs (cDNA7.1 and cDNA3.2) are
represented by red rectangles and arrows.  a, b and c indicate the pairs of primers used
in the RT-PRC reactions shown in B.  (B) RT-PCR products using the pairs of primers
a, b and c from D. melanogaster embryonic (E), third instar larvae (L) and wing
imaginal discs (wd) mRNA.  The asterisk indicated the amplified band. Rp49
amplification was used as control.  (C) PCR using A. gambiae cDNA library as template
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and specific a, b and c pairs of primers. (D) in situ hybridisation using anti-sense
RNA probes for dskiS (7233) or dskiL (7093) transcripts, either on wild type (WT) or
EP-M67/+;Gal4-sal/+ (M67) third instar wing imaginal discs.
Figure 3
Phylogenetic analysis of the Ski superfamily of proteins
(A) Unrooted dendogram showing three main branches: In blue, the Ski/Sno family that
includes CG7233 from Drosophila (Ski domain consensus RLCLPQ); in orange, the
Dachshund family that includes the only C. elegans homolog Dac1 (consensus
LICLPQ); in purple the CG11093-like family that includes also the LBXCO1 members
(consensus RLCLAQ).  See also Supplementary Fig. 1.  (B, C) Alignments of the Ski-
domain (B) and the Smad4 binding domain (C) from the Ski/Sno family members.  Red
arrows indicate the amino acid changes in the EP-M67 revertant mutants. Ag, A.
gambiae; Ce, C. elegans; Dm, D. melanogaster; Dp, D. pseudoobscura, Dr, zebrafish;
Gg, chicken; Hs, human; Mm, mouse; LBXCO1: Ladybird homeobox corepressor 1.
Figure 4
Effects of dSki, Dad and Brk on the expression of Dpp targets in wing discs
(A-E) Wild-type third instar wing discs showing the expression of Sal (A), omb-lacZ
(B), Bs (C), dad-lacZ (D) and brk-lacZ (E).  Gal4-sal/EP-M67 (G-K), Gal4-sal/UAS-
brk (M-Q) and Gal4-sal/UAS-dad (S-W) third instar wing showing the expression of
Sal (G,M,S), omb-lacZ (H,N,T), Bs (I,O,U), dad-lacZ (J,P,V) and brk-lacZ (K,Q,W).
(F, L, R, X) Adult wings of wild-type (F), Gal4-sal/EP-M67 (L), Gal4-sal/UAS-brk (R)
or Gal4-sal/UAS-dad (X) genotypes.
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Figure 5
Genetic interactions between dSki and different members of the Dpp pathway
(A) Adult wings of combinations between the Gal4 line Gal4-sal and the UAS lines
UAS-tkv* (AI), UAS-babo* (AII), UAS-Med (AIII), UAS-Mad (AIV) and UAS-dSmad2
(AV).  (B) Adult wings co-expressing dSki and different members of the Dpp pathway in
the sal domain of expression, Gal4-sal, EP-M67/UAS-tkv* (BI), Gal4-sal, EP-
M67/UAS-babo* (BII), Gal4-sal EP-M67/UAS-Med (BIII), Gal4-sal EP-M67/UAS-Mad
(BIV) and Gal4-sal EP-M67/UAS-dSmad2 (BV).  (C) Adult wings over-expressing in the
entire wing blade (Gal4-nub) different members of the Dpp pathway.  UAS-tkv* (CI),
UAS-babo* (CII), UAS-Med (CIII), UAS-Mad (CIV) and UAS-dSmad2 (CV).  (D) Adult
wings co-expressing dSki and different members of the Dpp pathway in the nub pattern
of expression.  Gal4-nub, EP-M67/UAS-tkv* (DI), Gal4-nub, EP-M67/UAS-babo* (DII),
Gal4-nub, EP-M67/UAS-Med (DIII), Gal4-nub, EP-M67/UAS-Mad (DIV) and Gal4-nub,
EP-M67/UAS-dSmad2 (DV).  (E-J) P-Mad expression in third instar wing imaginal discs
from wild type (E) or from the genetic combinations Gal4-nub/EP-M67 (F), Gal4-nub
/UAS-tkv* (G), Gal4-nub /UAS-dad (H), Gal4-nub, EP-M67/UAS-tkv* (I) or Gal4-nub,
EP-M67/UAS-dad (J).
Figure 6
Identification and characterization of dSki mutants
(A) Representation of the dSkiS protein, showing the Ski domain (orange) and the
Smad4-binding domain (red).  The amino acid substitutions present in each mutant
protein are shown below the black lines.  Numbers correspond to the localization of the
affected amino acids.  (B-J)  Adult wings of combinations between Gal4-638 and
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different EP-M67 revertant chromosomes: (B) Gal4-638/EP-M671D1, (C) Gal4-
638/EP-M673K1 (D) Gal4-638/EP-M67F3, (E) Gal4-638/EP-M672C3, (F) Gal4-638/EP-
M67R102, (G) Gal4-638/EP-M67S2, (H) Gal4-638/EP-M673W1 (I) Gal4-638/EP-M67V2, (J)
Gal4-638/EP-M67K2.  Below each wing is shown the position of the corresponding
amino acid substitution.  (K-M) Partial rescue of Mad by EP-M672C3 over-expression.
(K) Gal4-nub/UAS-Mad, (L) Gal4-nub/EP-M67; UAS-Mad/+, (M) Gal4-nub/EP-
M672C3; UAS-Mad/+.
Figure 7
Subcellular localization of dSkiS-GFP in wing discs
(A) Representation of the different dSki-GFP fusion proteins.  Coloured lines indicate
the Ski, Smad4 and Smad2/3 binding domains.  The C-terminal peptide is underlined in
blue.  Amino acids VRWV are spliced out in dSkiL.  (B-D) Adult wings of the
following genotypes: Gal4-nub/EP-M67 (M67; B); Gal4-nub/UAS-dSkiS-GFP (dSkiS-
GFP; C) and Gal4-nub/UAS-dSkiSΔC-GFP (dSkiSΔC-GFP; D).  (E-E’)  Expression of
GFP (green in E and E’) and Sal (red in E) in Gal4-nub/UAS-dSkiSΔC-GFP.  (F)
Expression of GFP (green in F and F’) and Het1 (red in F) in Gal4-sal/UAS-dSkiSΔC-
GFP third instar discs wing imaginal discs.  (G-G’) Expression of GFP (green in G and
G’) and Sal (red in G) in Gal4-nub/UAS-dSkiS-GFP third instar wing discs.  (H)
Expression of GFP in Gal4-nub/UAS-dSkiS-GFP; UAS-tkv*/+ third instar wing discs (I-
I’) Expression of GFP (green) and Sal (red) in Gal4-nub/UAS-dSkiS-GFP; UAS-Med/+
third instar wing discs.  I’ is a tangential sections of the disc shown in I.
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Figure 8
Differential subcellular localisation of dSki in cultured cells and its effect on
transcriptional activation and cell viability. (A-J) Immunocytochemistry on Cos1 cells
transfected with the indicated constructs. (A-H) Cells are transfected with dSkiS-GFP in
the absence (A,C,E,G) or presence (B,D,F,H) of Tkv*. (I-J) Cells are transfected with
dSkiL-GFP in the absence (I) or presence (J) of Tkv*. (K,L) Graphical representations
where the Y-axes represent times of activation of TLX2-Lux (K) or percentage of viable
cells (L) in P19 cultures under to the presence of the indicated constructs.  T-test values
are shown. Bars indicate standard deviation.








